Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 24,273Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 20TAIHO ONCOLOGY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-2503

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-22

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-1751

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2029-09-22

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-1751

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2029-09-22

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-2503

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-22

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3656

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-22

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : RE46284

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3656

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-22

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : 10456399

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3657

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-03

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : 10456399

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3658

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-03

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : 10456399

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3658

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-03

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

US Patent Number : 10456399

Drug Substance Claim :

Drug Product Claim :

Application Number : 207981

Patent Use Code : U-3657

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-02-03

blank